Stay updated on Biomarker Analysis in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker Analysis in Urothelial Cancer Clinical Trial page.

Latest updates to the Biomarker Analysis in Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section text updated to clarify that publications are automatically filled from PubMed and may not all pertain to the study. Revision note updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedA government funding status notice was removed from the page. This does not affect the study details or user actions on the trial record.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new screenshot shows only minor layout and formatting changes; core study content (eligibility criteria, endpoints, and Pembrolizumab treatment details) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference3%

- Check69 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Back to Top link removed.SummaryDifference0.2%

Stay in the know with updates to Biomarker Analysis in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Analysis in Urothelial Cancer Clinical Trial page.